A phase II study in patients with Alzheimer's disease to...

A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon®)

Françoise Forette, Ravi Anand, George Gharabawi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
1999
Pages:
7
DOI:
10.1046/j.1468-1331.1999.640423.x
File:
PDF, 870 KB
1999
Conversion to is in progress
Conversion to is failed